Harrow, Inc.
HROW
#5831
Rank
C$1.72 B
Marketcap
C$46.01
Share price
-0.09%
Change (1 day)
-17.26%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): -C$15.17 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are C$0.27 Billion. In 2025 the company made an earning of C$32.66 Million, an increase over its 2024 earnings that were of C$7.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$15.17 Million-146.42%
2025 C$32.66 M317.34%
2024 C$7.82 M-329.09%
2023 -C$3.42 Million-224.34%
2022 C$2.74 M3.01%
2021 C$2.66 M149.06%
2020 C$1.07 M434.29%
2019 C$0.2 M-102.68%
2018 -C$7.48 Million-57.11%
2017 -C$17.42 Million-21.93%
2016 -C$22.31 Million5.11%
2015 -C$21.23 Million46.16%
2014 -C$14.53 Million32.68%
2013 -C$10.95 Million42.63%
2012 -C$7.68 Million
2010 -C$3.55 Million-45.76%
2009 -C$6.54 Million21.83%
2008 -C$5.37 Million-491.97%
2007 C$1.36 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.23 Billion 1,423.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$26.01 Million 73.81%๐Ÿ‡บ๐Ÿ‡ธ USA